Skip to main content
Log in

Subtype determination of presynaptic α2-autoreceptors in the rabbit pulmonary artery and human saphenous vein

  • Original Article
  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Abstract

The pharmacological properties of the presynaptic α2-autoreceptors mediating inhibition of noradrenaline release were investigated in human saphenous vein and rabbit pulmonary artery. Segments of these blood vessels were incubated with [3H]noradrenaline and subsequently superfused with physiological salt solution containing uptake1 and uptake2 blockers. The potencies of α2-adrenoceptor antagonists in facilitating (pEC40) the electrically (2 Hz) evoked tritium overflow were determined. The order of potency and potency ratios of α2-adrenoceptor antagonists obtained in our experiments were compared with the corresponding order of affinity and affinity ratios from radioligand binding studies in tissues and cells expressing only one of the α2-adrenoceptor subtypes.

In the rabbit pulmonary artery, oxymetazoline was a highly potent agonist at presynaptic α2-adrenoceptors, as reflected by its ability to inhibit at low concentrations the electrically evoked tritium overflow. However, in the human saphenous vein oxymetazoline behaved as a partial agonist, which, in interaction experiments with the α2-adrenoceptor agonist B-HT 920 (2-amino-6-ally,-5,6,7,8-tetrahydro-4H-thiazolo-[4,5-d]-azepine), exhibited high potency in antagonizing the inhibitory effect of the latter drug on tritium overflow. Prazosin given alone at concentrations up to 1 μmol/1 did not affect tritium overflow. The data obtained with oxymetazoline and prazosin make it very improbable that the α2-autoreceptors on the sympathetic nerves in both tissues are of the α2B- or α2c-subtype. In both blood vessels, rauwolscine given alone was highly potent in facilitating the electrically evoked overflow. In agreement with this, rauwolscine exhibited high potency in antagonizing the inhibitory effect of oxymetazoline on tritium overflow in the rabbit pulmonary artery and of B-HT 920 in the human saphenous vein. The ratio phentolamine/rauwolscine calculated from their potencies in increasing the electrically evoked tritium overflow was also used to discriminate between the various α2-adrenoceptor subtypes. Comparison of this potency ratio with the corresponding affinity ratios for α2-adrenergic binding sites on HT 29 cells, human platelets, bovine pineal gland, rat submaxillary gland, and cell lines transfected with the human α2 genes indicates that in the rabbit pulmonary artery and human saphenous vein the pharmacological characteristics of the autoreceptors conform best to those of α2A-adrenoceptors. Finally, in both blood vessels the potencies of the antagonists BDF 6143 (4-chloro-2-(2-imidazolin-2-ylamino)-isoindoline), rauwolscine, corynanthine, phentolamine, idazoxan, SKF 104078 (6-chloro-9-[(3-methyl-2-butenyl) oxyl]-3-methyl-lH-2,3,4,5-tetrahydro-3-benzazepine), and/or tolazoline in facilitating evoked noradrenaline release was determined. The potencies of these drugs which can discriminate between α2A- and α2D-adrenoceptors (but not between these and α2B/2c-adrenoceptors) were correlated significantly with their affinities for α2A, but not α2D, sites in radioligand binding studies.

In conclusion, the present results suggest that the sympathetic nerves of the human saphenous vein and rabbit pulmonary artery are endowed with α2-autoreceptors of the α2A subtype.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Blaxall HS, Murphy TJ, Baker JC, Ray C, Bylund DB (1991) Characterization of alpha-2C adrenergic receptor subtype in the opossum kidney and in the OK cell line. J Pharmacol Exp Ther 259:323–329

    CAS  PubMed  Google Scholar 

  • Bylund DB, Ray-Prenger C, Murphy TJ (1988a) Alpha-2A and alpha-2B adrenergic receptor subtypes: antagonist binding in tissues and cell lines containing only one subtype. J Pharmacol Exp Ther 245:600–607

    Google Scholar 

  • Bylund DB, Rudeen PK, Petterborg LJ, Ray-Prenger C (1988b) Identification of α2-adrenergic receptors in chicken pineal gland using [3H]rauwolscine. J Neurochem 51:81–86

    Google Scholar 

  • Bylund DB, Blaxall HS, Iversen LJ, Caron MG, Lefkowitz RJ, Lomasney JW (1992) Pharmacological characteristics of α2-adrenergic receptors: comparison of pharmacologically defined subtypes with subtypes identified by molecular cloning. Mol Pharmacol 42:1–5

    CAS  PubMed  Google Scholar 

  • Bylund DB, Eikenberg DC, Hieble JP, Langer SZ, Lefkowitz RJ, Minneman KP, Molinoff PB, Ruffolo RR, Trendelenburg U (1994) International union of pharmacology nomenclature of adrenoceptors. Pharmacol Rev 46:121–136

    CAS  PubMed  Google Scholar 

  • Doxey JC, Everitt J (1977) Inhibitory effects of clonidine on responses to sympathetic nerve stimulation in the pithed rat. Br J Pharmacol 61:559–566

    Google Scholar 

  • Endo T, Starke K, Bangerter A, Taube HD (1977) Presynaptic receptors systems on the noradrenergic neurones of the rabbit pulmonary artery. Naunyn-Schmiedeberg's Arch Pharmacol 296:229–247

    Google Scholar 

  • Furchgott RF (1972) The classification of adrenoceptors (adrenergic receptors). An evaluation from the standpoint of receptor theory. In: Blaschko H, Muscholl E (eds.) Handbook of Experimental Pharmacology. (Catecholamines, vol XXXIII) Springer, Berlin Heidelberg New York, pp 283–335

    Google Scholar 

  • Garcia-Sevilla JA, Fuster MJ (1986) Labelling of human platelet α2-adrenoceptors with the full agonist [3H](−)adrenaline. Eur J Pharmacol 124:31–41

    Google Scholar 

  • Göthert M, Molderings GJ (1991) Involvement of presynaptic imidazoline receptors in the α2-adrenoceptor-independent inhibition of noradrenaline release by imidazoline derivatives. Naunyn-Schmiedeberg's Arch Pharmacol 343:271–282

    Google Scholar 

  • Göthert M, Dieckhöfer C, Nolte J (1983) Preferential blockade of α1-adrenoceptors in the rabbit pulmonary artery by derivatives of β-phenylethylamine chemically related to BE 2254 (HEAT). J Cardiovasc Pharmacol 5:12–18

    Google Scholar 

  • Göthert M, Schlicker E, Hentrich F, Rohm N, Zerkowski HR (1984) Modulation of noradrenaline release in human saphenous vein via presynaptic α2-adrenoceptors. Eur J Pharmacol 102:261–267

    Google Scholar 

  • Göthert M, Molderings GJ, Fink K, Schlicker E (1995) α2-Adrenoceptor-independent inhibition by imidazolines and guanidines of noradrenaline release from peripheral, but not central noradrenergic neurones. N Y Acad Sci 763:405–419

    Google Scholar 

  • Harrison JK, D'Angelo DD, Zeng D, Lynch KR (1991) Pharmacological characterization of rat α2-adrenergic receptors. Mol Pharmacol 40:407–412

    Google Scholar 

  • Lattimer N, Rhodes KF (1985) A difference in the affinity of some selective α2-adrenoceptor antagonists when compared on isolated vasa deferentia of rat and rabbit. Naunyn-Schmiedeberg's Arch Pharmacol 329:278–281

    Google Scholar 

  • Lawhead RG, Blaxall HS, Bylund DB (1992) α-2A is the predominant α-2 adrenergic receptor subtype in human spinal cord. Anesthesiology 77:983–991

    Google Scholar 

  • Limberger N, Fischer MRG, Wichmann T, Starke K (1989) Phentolamine blocks presynaptic serotonin autoreceptors in rabbit and rat brain cortex. Naunyn-Schmiedeberg's Arch Pharmacol 340:52–62

    Google Scholar 

  • Limberger N, Späth L, Starke K (1991) Subclassification of the presynaptic α2-autoreceptor in rabbit brain cortex. Br J Pharmacol 103:1251–1255

    Google Scholar 

  • Limberger N, Trendelenburg AU, Starke K (1992) Pharmacological characterization of presynaptic α2-autoreceptors in rat submaxillary gland and heart atrium. Br J Pharmacol 107:246–255

    Google Scholar 

  • Limberger N, Funk L, Trendelenburg AU, Starke K (1995) Subclassification of presynaptic α2-adrenoceptors: α2A-autoreceptors in rabbit atria and kidney. Naunyn-Schmiedeberg's Arch Pharmacol 352:31–42

    Google Scholar 

  • MacKinnon AC, Kilpatrick AT, Kenny BA, Spedding M, Brown CM (1992) [3H]-RS-15385–197, a selective and high affinity radioligand for α2-adrenoceptors: implications for receptor classification. Br J Pharmacol 106:1011–1018

    Google Scholar 

  • MacKinnon AC, Spedding M, Brown CM (1993) Sodium modulation of 3H-agonist and 3H-antagonist binding to α2-adrenoceptor subtypes. Br J Pharmacol 109:371–378

    Google Scholar 

  • Marjamäki A, Luomola K, Ala-Uodla S, Scheinin M (1993) Use of recombinant human α2-adrenoceptors to characterize subtpye selectivity of antagonist binding. Eur J Pharmacol 246:219–226

    Google Scholar 

  • Michel AD, Loury DN, Whiting RL (1989) Differences between the α2-adrenoceptor in the rat submaxillary gland and the α2A- and α2B-adrenoceptor subtypes. Br J Pharmacol 98:890–897

    Google Scholar 

  • Molderings GJ, Göthert M (1992) Pharmacological characterization of the inhibitory α2-autoreceptors on the sympathetic nerves of the rabbit pulmonary artery. Naunyn-Schmiedeberg's Arch Pharmacol 345 [Suppl 2]:R64

    Google Scholar 

  • Molderings GJ, Göthert M (1993) Pharmacological characterization of the inhibitory α2-autoreceptors on the sympathetic nerves of human, rat and rabbit blood vessels. Fundam Clin Pharmacol 7:372

    Google Scholar 

  • Molderings GJ, Göthert M (1994) The inhibitory α2-autoreceptors on the sympathetic nerves of human, rat and rabbit blood vessels belong to different subtypes. Can J Physiol Pharmacol 72 [Supp 14]:32

    Google Scholar 

  • Molderings GJ, Hentrich F, Göthert M (1991) Pharmacological characterization of the imidazoline receptor which mediates inhibition of noradrenaline release in the rabbit pulmonary artery. Naunyn-Schmiedeberg's Arch Pharmacol 344:630–638

    Google Scholar 

  • Murphy TJ, Bylund DB (1988) Characterization of alpha-2 adrenergic receptors in the OK cell, an opossum kidney cell line. J Pharmacol Exp Ther 244:571–578

    Google Scholar 

  • Nedergaard OA (1988) Frequency-dependence of 3H-noradrenaline release from rabbit pulmonary artery: effect of α-adrenoceptor antagonists and inhibitors of transmitter inactivation. Pharmacol Toxicol 63:317–323

    Google Scholar 

  • O'Rourke MF, Iversen LJ, Lomasney JW, Bylund DB (1994) Species orthologs of the alpha-2A adrenergic receptor: the pharmacological properties of the bovine and rat receptors differ from the human and porcine receptors. J Pharmacol Exp Ther 271:735–740

    Google Scholar 

  • Raiteri M, Bonanno G, Maura G, Pende M, Andrioli GC, Ruelle A (1992) Subclassification of release-regulating α2-autoreceptors in human brain cortex. Br J Pharmacol 107:1146–1151

    CAS  PubMed  Google Scholar 

  • Regan JW, Kobilka TS, Yang-Feng TL, Caron MG, Lefkowitz RJ, Kobilka BK (1988) Cloning and expression of a human kidney cDNA for an alpha2-adrenergic receptor subtype. Proc Natl Acad Sci USA 85:6301–6305

    CAS  PubMed  Google Scholar 

  • Renouard A, Widdowson PS, Millan MJ (1994) Multiple α2 adrenergic receptor subtypes. I. Comparison of [3H]RX821002-labeled rat Ralpha-2A adrenergic receptors in cerebral cortex to human HAlpha2A adrenergic receptor and other populations of alpha-2 adrenergic subtypes. J Pharmacol Exp Ther 270:946–957

    Google Scholar 

  • Schoeffter P, Hoyer D (1991) Interaction of the α-adrenoceptor agonist oxymetazoline with serotonin 5-HT1A, 5-HT1B, 5-HT1C and 5-HT1D receptors. Eur J Pharmacol 196:213–216

    Google Scholar 

  • Simonneaux V, Ebadi M, Bylund DB (1991) Indentification and characterization of α2D-adrenergic receptors in bovine pineal gland. Mol Pharmacol 40:235–241

    Google Scholar 

  • Starke K (1981) α-Adrenoceptor classification. Rev Physiol Biochem Pharmacol 88:199–236

    Google Scholar 

  • Starke K, Docherty JR (1980) Recent developments in α-adrenoceptor research. J Cardiovase Pharmacol 2 [Suppl 3]:5269–5286

    Google Scholar 

  • Starke K, Endo T, Taube HD (1975) Relative pre- and postsynaptic potencies of the α-adrenoceptor agonists in the rabbit pulmonary artery. Naunyn-Schmiedeberg's Arch Pharmacol 291:55–78

    Google Scholar 

  • Starke K, Göthert M, Kilbinger H (1989) Modulation of neurotransmitter release by presynaptic autoreceptors. Physiol Rev 69:864–989

    Google Scholar 

  • Su C, Bevan JA (1970) The release of 3H-norepinephrine in arterial strips studied by the technique of superfusion and transmural stimulation. J Pharmacol Exp Ther 172:62–68

    Google Scholar 

  • Trendelenburg AU, Limberger N, Starke K (1993) Presynaptic α2-autoreceptors in brain cortex: α2D in the rat and α2A in the rabbit. Naunyn-Schmiedeberg's Arch Pharmacol 348:35–45

    Google Scholar 

  • Trendelenburg AU, Limberger N, Rump LC (1994) α2-Adrenergic receptors of the α2C subtype mediate inhibition of norepinephrine release in human kidney cortex. Mol Pharmacol 45:1168–1176

    Google Scholar 

  • Uhlén S, Wikberg JES (1991) Rat spinal cord α2-adrenoceptors are of the α2A-subtype: comparison with α2A- and α2B-adrenoceptors in rat spleen, cerebral cortex and kidney using 3H-RX821002 ligand binding. Pharmacol Toxicol 69:341–350

    Google Scholar 

  • Verbeuren TJ, Jordaens FH, Zonnekeyn LL, Herman AG (1986) Effect of the amino-oxazoline derviative S-3341 on pre- and postjunctional α-adrenoceptors in isolated blood vessels. Arch Int Pharmacodyn Ther 284:38–52

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Molderings, G.J., Göthert, M. Subtype determination of presynaptic α2-autoreceptors in the rabbit pulmonary artery and human saphenous vein. Naunyn-Schmiedeberg's Arch Pharmacol 352, 483–490 (1995). https://doi.org/10.1007/BF00169381

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00169381

Key words

Navigation